US drug regulator issues warning letter to Sun Pharma on CGMP
Indian drug major Sun Pharmaceutical’s western Indian facility of Halal has been issued a warning letter by the FDA for not conforming to Current Good.
Drugs
Pharma
Drugs
Medical
Pharma
Every 4.4 seconds, a child or youth died in 2021: WHO
A child or youth died every 4.4 seconds in 2021 and about five million children died before their fifth birthday, due to labor.
Drugs
Pharma
AstraZeneca to acquire US-based CinCor for $1.8 billion
AstraZeneca, a British-Swedish global pharmaceutical and biotechnology company, will buy CinCor Pharma, Inc., for $1.8 billion, according to a statement.
Drugs
Health
Medical
A dietary supplement helps reverse signs of heart disease
Researchers have found that dietary supplement Tricaprin can help reverse heart disease due to plaque deposit
Drugs
Pharma
Combined dish-and-chip technology to open ways to treat kidney disorder
US scientists have combined two technologies to show the effect of glucose in polycystic kidney disorder, a life-threatening genetic disorder, according to a.
Drugs
Pharma
Moderna in $35 million licensing deal with CytomX
Moderna, a US-based biotechnology company, announced a $35 million licensing deal with cancer-focused drugmaker CytomX to develop messenger RNA therapies.
Drugs
Pharma
FDA gives accelerated approval for Alzheimer’s drug
The FDA has granted accelerated approval for an intravenous drug to treat Alzheimer's Disease, according to a statement.
Drugs
Pharma
Dabur India forecasts low to single-digit Q3 revenue growth
Dabur India, an ayurvedic and natural healthcare company, forecasts a low to mid-single-digit revenue growth for the third quarter ending December 31 due.
Drugs
Pharma
India starts anti-dumping probe into vitamin, adhesive vinyl imports from China, EU
Investigators from India's Director General of Trade Remedies have started an anti-dumping probe into vitamin A palmitate imports from China, the EU and.
Drugs
Health
Pharma
Omicron variants make up 97.5% of all China infections: WHO
There is a predominance of Omicron BA. 5.2 and BF.7 Covid-19 lineages, accounting for 97.5% of all local infections in China, according to.